Previous close | 302.11 |
Open | 283.30 |
Bid | 304.37 x 0 |
Ask | 304.50 x 0 |
Day's range | 300.35 - 307.34 |
52-week range | 253.48 - 325.00 |
Volume | |
Avg. volume | 3,920,461 |
Market cap | 369.297B |
Beta (5Y monthly) | 0.08 |
PE ratio (TTM) | 30.31 |
EPS (TTM) | 10.05 |
Earnings date | 06 May 2024 - 13 May 2024 |
Forward dividend & yield | 8.80 (2.89%) |
Ex-dividend date | 22 Nov 2023 |
1y target est | 391.76 |
In this article, we will look at the 15 countries with the highest life expectancy in Asia. If you wish to skip our detailed analysis, you can go directly to 5 Countries with the Highest Life Expectancy in Asia. An Overview of Variations in Average Life Expectancy People across the world are living longer than […]
A mainland Chinese buyer snapped up an ultra-luxury house at The Peak in Hong Kong at a 35 per cent discount, reflecting the still lukewarm atmosphere in the city's luxury property market. The mansion, 25-26 A&B Lugard Road, sold for HK$838 million (US$107 million), or HK$71,703 per square foot, according to Godfrey Cheng, deputy senior director of the investment CEO office at Savills Hong Kong, the sole agent for the property. The sale is linked to Shenzhen entrepreneur Xu Hang, co-founder and
Mindray (SZSE: 300760), a global leader in medical devices and solutions, introduces high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The additions have enhanced Mindray's diverse portfolio of cardiac biomarkers for cardiovascular diseases (CVDs) diagnosis and management.